Porównaj metody

	Wskaźnik Kardynalnych Objawów Gastroparezy	Prosty wskaźnik aktywności klinicznej zapalenia jelita grubego
Dziedzina	Gastroenterologia	Gastroenterologia
Rodzina	Process / pipeline	Process / pipeline
Rok powstania	2003	1998
Twórca	Revicki, D. A., Rentz, A. M., Dubois, D., et al.	Walmsley, R. S., Ayres, R. C., Pounder, R. E., and Allan, R. N.
Typ	Self-report	Clinician-rated
Źródło pierwotne	Revicki, D. A., Rentz, A. M., Dubois, D., Kahrilas, P., Stanghellini, V., Talley, N. J., & Tack, J. (2003). Development and validation of a patient-assessed gastroparesis symptom severity index. Alimentary Pharmacology & Therapeutics, 18(1), 141–150.	Walmsley, R. S., Ayres, R. C., Pounder, R. E., & Allan, R. N. (1998). A simple clinical colitis activity index. Gut, 43(1), 29–32.
Inne nazwy	GCSI	SCCAI
Pokrewne	4	4
Podsumowanie	The Gastroparesis Cardinal Symptom Index (GCSI) is a validated, patient-reported outcome measure specifically designed to assess symptom severity in gastroparesis. Developed by Revicki and colleagues in 2003, the GCSI captures the three cardinal symptom clusters of gastroparesis: nausea and vomiting, postprandial fullness, and early satiety, plus bloating and stomach distension. The 9-item questionnaire is responsive to treatment changes and is increasingly used in clinical trials and practice to monitor gastroparesis progression and therapy response.	The Simple Clinical Colitis Activity Index (SCCAI) is a practical, bedside tool for assessing disease activity in ulcerative colitis and colonic Crohn's disease. Published in 1998 by Walmsley and colleagues, the SCCAI condenses disease assessment into six items that can be administered in a office visit without laboratory or endoscopic data. It provides rapid, reproducible quantification of disease severity and is ideal for frequent monitoring in routine clinical practice.